Clinical trials: Around half of new treatments perform better than existing treatments

Researchers show that uncertainty about new treatments meets ethical requirements

2012-10-17

(Press-News.org) On average, new treatments perform better in clinical trials only slightly more often than existing treatments, according to a new systematic review published in The Cochrane Library. The fact that experimental treatments are not more effective may seem disappointing, but the authors of the review say their findings satisfy an important ethical requirement for clinical trials.

Randomised trials compare the effects of one treatment to another. In a randomised trial patients are randomly allocated to different treatment groups to ensure that like will be compared with like. When a new treatment is being tested, it is hoped or even expected that it will be better than the established treatment with which it is being compared. These expectations lead to an ethical dilemma. If the researchers already know that one treatment is better, they would be knowingly allocating some people to an inferior treatment. If randomised trials are to be ethical, therefore, only half of new treatments should turn out to be better than existing ones.

Cochrane researchers looked at evidence from 743 publicly funded randomised trials involving 297,744 patients in total. The trials included new, experimental treatments for cancer and neurological disorders, as well as a range of other diseases. On average, only very slightly more than half of new treatments proved to be better than established treatments.

"When we compared the effects of new treatments to established ones, the pattern was almost symmetrical. This is good news, because it means researchers genuinely don't know whether new treatments are going to be any better," said lead researcher Benjamin Djulbegovic, who works at USF Health Clinical Research, and the H. Lee Moffitt Cancer Center & Research Institute, at the University of South Florida in Tampa, Florida, US. "So, overall, what we show is that we can expect the new treatments to perform better a little bit more often than established treatments, at least in publicly funded trials like the ones we considered."

The researchers found the same pattern in trials going back five decades. The results provide an answer to the question posed 15 years ago in the British Medical Journal by Iain Chalmers, a founder of the Cochrane Collaboration and one of the authors of the review. "In 1997, in a letter published in the BMJ, I asked 'What is the prior probability of a proposed new treatment being superior to established treatments?' I think this review currently provides the best answer to that question," said Chalmers.

###

ELSE PRESS RELEASES FROM THIS DATE:

Common medical screen predicts liver cancer risk in general population

2012-10-17

HOUSTON — Enzyme levels in the blood routinely monitored by physicians as liver function indicators are also the best predictor of liver cancer risk for the general population, a team of scientists in Taiwan and The University of Texas MD Anderson Cancer Center reports today in the Journal of the National Cancer Institutet. "These two enzymes alone predicted 91 percent of liver cancer cases in our prospective study," said paper senior author Xifeng Wu, M.D., Ph.D., professor and chair of MD Anderson's Department of Epidemiology. "If our research is confirmed in other ...

Pluto's moons and possible rings may be hazards to New Horizons spacecraft

2012-10-17

NASA's New Horizons spacecraft is now almost seven years into its 9.5-year journey across the solar system to explore Pluto and its system of moons. Just over two years from now, in January 2015, New Horizons will begin encounter operations, which will culminate in a close approach to Pluto on July 14, 2015, and the first-ever exploration of a planet in the Kuiper Belt. As New Horizons has traveled through the solar system, its science team has become increasingly aware of the possibility that dangerous debris may be orbiting in the Pluto system, putting NASA's New Horizons ...

Vitamin D supplements may benefit lupus patients

2012-10-17

A new clinical study published in BioMedCentral's open access journal Arthritis Research and Therapy provides preliminary evidence that vitamin D supplementation could be considered an immunomodulatory agent for systemic lupus erythematosus (SLE), a debilitating autoimmune disease characterized not only by skin, joint, neurological and renal symptoms, but also by inflammation of tissue linings in the body. SLE is a T- and B-cell-dependent disease that causes an appearance of autoantibodies, causing the body to attack itself. Patients present with a depletion of regulatory ...

Muscle relaxants linked with increased risk of breathing problems after surgery

2012-10-17

Muscle relaxants given to millions of patients during general anaesthesia are associated with an increased risk of serious breathing problems after surgery, finds a study published on bmj.com today. The results also suggest that giving drugs to reverse the muscle relaxants after surgery may increase the risk further. But an accompanying editorial argues that, in modern medicine, general anaesthesia is an extremely safe procedure and it would be a mistake to change clinical practice on the basis of this one study, however large and well executed. Known as intermediate ...

Drugs used to immobilize patients during surgery raise risk of respiratory complications

2012-10-17

Massachusetts General Hospital (MGH) researchers have found that medications currently used to immobilize patients during surgery can increase the risk of postoperative respiratory complications. Their study being published online in the journal BMJ also found that the agent most commonly used to reverse the action of the immobilizing drug does not prevent and may possibly increase the risk that patients will need to receive postoperative respiratory support. "Neuromuscular blocking agents are used during surgery for a variety of reasons, including allowing placement ...

Many options available to help smokers kick the habit

2012-10-17

Smokers who have tried to quit and failed may be tempted to just give up, particularly if they hear statistics like the fact that most quit attempts will be unsuccessful. But smokers today have many options to help them quit, and those who think they have "tried it all" usually have not. In a report in the Oct. 17 issue of JAMA, Nancy Rigotti, MD, director of the Tobacco Research and Treatment Center of the Massachusetts General Hospital (MGH) Department of Medicine, outlines currently available resources and recommends strategies that can help smokers who are struggling ...

New HIV prevention technology shows promise

2012-10-17

ARLINGTON, VA -- CONRAD researchers, in collaboration with engineers at the University of Utah, have designed a 90-day intravaginal ring that can be used by women to prevent the sexual transmission of HIV. A study of the ring used sheep to determine whether safe, effective and steady doses of the antiretroviral drug tenofovir can be released over 90 days. This research is being presented at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in Chicago, Ill., Oct. 14 – 18 and will be published in the 12th issue of Antimicrobial ...

New study aims to predict risk of cancer

2012-10-17

New research at the University of Southampton aims to develop a way of predicting who is more at risk of getting cancer. Led by Paul Little, Professor of Primary Care Research, the CANcer DIagnosis Decision rules (CANDID) study, funded by the National Institute for Health Research (NIHR) School for Primary Care Research (NIHR SPCR), will collect and analyse clinical information and blood samples from 20,000 patients who have had lung or colon cancer. The aim is to determine which signs and symptoms are most predictive of those who go on to be diagnosed with the disease. ...

Mother's touch could change effects of prenatal stress

2012-10-17

Scientists at the Universities of Liverpool, Manchester, and Kings College, London, have found that mothers who stroke their baby's body in the first few weeks after birth may change the effects that stress during pregnancy can have on an infant's early-life development. Researchers world-wide have been studying whether stress in pregnancy can lead to emotional and behavioural problems in children for many years. Attention is now moving towards how parents might alter these effects after birth. Researchers are aiming to improve understanding of the issues to help ...

Shape of urine can indicate prostate issues

2012-10-17

Scientists at Queen Mary, University of London have discovered that the characteristic shape of a man's urine stream could be used to help diagnose urinary problems. The research, published in PLOS One today (16 October) is the first study to analyse the specific pattern a man's urine makes and whether it could be used to detect prostate problems. Co-author Dr Martin Knight from Queen Mary's School of Engineering and Materials Science explained: "The characteristic shape is due to the surface tension in the urine and the elliptical shape of the urethra. "The computer ...

DARPA-ABC program supports Wyss Institute-led collaboration toward deeper understanding of anesthesia and safe drugs enabling anesthesia without the need for extensive monitoring

Davos Alzheimer's Collaborative launches innovative brain health navigator program for intuitive coordination between patients and providers

Large-scale TMIST breast cancer screening trial achieves enrollment goal, paving the way for data that provides a precision approach to screeninge

Study published in NEJM Catalyst finds patients cared for by MedStar Health’s Safe Babies Safe Moms program have better outcomes in pregnancy, delivery, and postpartum

Clinical trials: Around half of new treatments perform better than existing treatments

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: